World Congress of Cardiology 2014
GPTKB entity
Statements (51)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:event
|
gptkbp:attendees |
cardiologists
|
gptkbp:collaborator |
universities
government agencies non-profit organizations health organizations international cardiology societies |
gptkbp:community_outreach |
community health initiatives
screening programs public health education patient support groups lifestyle modification programs |
gptkbp:date |
2014-05-07
2014-05-04 |
gptkbp:events |
World Congress of Cardiology 2016
|
gptkbp:exhibition |
gptkb:pharmaceuticals
gptkb:medical_devices research organizations |
gptkbp:feedback |
positive
constructive criticism |
gptkbp:focus |
cardiovascular diseases
|
gptkbp:held_in |
gptkb:Australia
|
https://www.w3.org/2000/01/rdf-schema#label |
World Congress of Cardiology 2014
|
gptkbp:legacy |
better patient outcomes
enhanced global collaboration increased research funding improved cardiovascular care strengthened professional networks |
gptkbp:location |
gptkb:Melbourne
|
gptkbp:media_coverage |
extensive
|
gptkbp:network |
yes
|
gptkbp:notable_speakers |
gptkb:Dr._John_Doe
|
gptkbp:organizer |
gptkb:World_Heart_Federation
|
gptkbp:outcome |
gptkb:educational_resources
awareness campaigns research collaborations advancements in treatment new guidelines |
gptkbp:publication |
gptkb:conference
|
gptkbp:session |
clinical trials
hypertension heart failure arrhythmias interventional cardiology preventive cardiology cardiac surgery cardiac imaging |
gptkbp:sponsor |
various pharmaceutical companies
|
gptkbp:theme |
Innovations in Cardiovascular Health
|
gptkbp:bfsParent |
gptkb:World_Congress_of_Cardiology_2012
|
gptkbp:bfsLayer |
6
|